bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figure S6 from IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer
Authors: Maynard Janielle P. , Ertunc Onur , Kulac Ibrahim , Baena-Del Valle Javier A. , De Marzo Angelo M. , Sfanos Karen S.
Published: April 2023

Supplementary Figure S6 shows cBioPortal data for IL-8 and AR expression in primary prostate cancer, metastatic, and neuroendocrine tumors as well as CXCR1, CXCR2, and AR co-expression.
Supplementary data and materials from Reprogramming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis
Authors: Wani Nissar Ahmad , Zhang Bo , Teng Kun-yu , Barajas Juan M. , Motiwala Tasneem , Hu Peng , Yu Lianbo , Brüschweiler Rafael , Ghoshal Kalpana , Jacob Samson T.
Published: April 2023

Fig. S1-S11, Tables S1-S2 and primer sequences
Supplementary Figure S4 from IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer
Authors: Maynard Janielle P. , Ertunc Onur , Kulac Ibrahim , Baena-Del Valle Javier A. , De Marzo Angelo M. , Sfanos Karen S.
Published: April 2023

Supplementary Figure S4 shows examples of liver metastases stained for IL-8 by RISH and CD66 by IHC as well as quantification of IL-8 and AR in metastatic tissues of AA versus EA men.
Supplementary Figure S3 from IL8 Expression Is Associated with Prostate Cancer Aggressiveness and Androgen Receptor Loss in Primary and Metastatic Prostate Cancer
Authors: Maynard Janielle P. , Ertunc Onur , Kulac Ibrahim , Baena-Del Valle Javier A. , De Marzo Angelo M. , Sfanos Karen S.
Published: April 2023

Supplementary Figure S3 shows quantification of CD66+ neutrophils in TMAs.
Figure S1 from STAT3 Targets ERR-α to Promote Epithelial–Mesenchymal Transition, Migration, and Invasion in Triple-Negative Breast Cancer Cells
Authors: Ma Jia-Hui , Qi Jie , Lin Shi-Qi , Zhang Cai-Yun , Liu Fang-yuan , Xie Wei-Dong , Li Xia
Published: April 2023

The whole data of Ch-IP (P1-P11).
Supplementary array CGH_Amplification-Deletion from SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia
Authors: Chatterjee Shankha Subhra , Biswas Mayukh , Boila Liberalis Debraj , Banerjee Debasis , Sengupta Amitava
Published: April 2023

Supplementary array CGH_Amplification-Deletion
Supplementary RNA-Seq_GENELIST from SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia
Authors: Chatterjee Shankha Subhra , Biswas Mayukh , Boila Liberalis Debraj , Banerjee Debasis , Sengupta Amitava
Published: April 2023

Supplementary RNA-Seq_GENELIST
Supplementary ChIP-seq_SMARCC1 Motif Analysis from SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia
Authors: Chatterjee Shankha Subhra , Biswas Mayukh , Boila Liberalis Debraj , Banerjee Debasis , Sengupta Amitava
Published: April 2023

Supplementary ChIP-seq_SMARCC1 Motif Analysis
Supplementary ChIP-seq_All Peaks from SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia
Authors: Chatterjee Shankha Subhra , Biswas Mayukh , Boila Liberalis Debraj , Banerjee Debasis , Sengupta Amitava
Published: April 2023

Supplementary ChIP-seq_All Peaks
Supplemental Legends from Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma
Authors: Zhang Xiaomeng , Tang Jian Zhong , Vergara Ismael A. , Zhang Youfang , Szeto Pacman , Yang Lie , Mintoff Christopher , Colebatch Andrew , McIntosh Lachlan , Mitchell Katrina A. , Shaw Evangeline , Rizos Helen , Long Georgina V. , Hayward Nicholas , McArthur Grant A. , Papenfuss Anthony T. , Harvey Kieran F. , Shackleton Mark
Published: April 2023

Supplemental Legends
Figure S4 from Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma
Authors: Zhang Xiaomeng , Tang Jian Zhong , Vergara Ismael A. , Zhang Youfang , Szeto Pacman , Yang Lie , Mintoff Christopher , Colebatch Andrew , McIntosh Lachlan , Mitchell Katrina A. , Shaw Evangeline , Rizos Helen , Long Georgina V. , Hayward Nicholas , McArthur Grant A. , Papenfuss Anthony T. , Harvey Kieran F. , Shackleton Mark
Published: April 2023

Correlation amongst melanoma cell lines of viability following YAP siRNA- and verteporfin-treatment
Table S1 from Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer
Authors: Dahl Erika S. , Buj Raquel , Leon Kelly E. , Newell Jordan M. , Imamura Yuka , Bitler Benjamin G. , Snyder Nathaniel W. , Aird Katherine M.
Published: April 2023

Primer sequences
Figure S6 from Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer
Authors: Dahl Erika S. , Buj Raquel , Leon Kelly E. , Newell Jordan M. , Imamura Yuka , Bitler Benjamin G. , Snyder Nathaniel W. , Aird Katherine M.
Published: April 2023

Senescence induced by IDH1 knockdown is independent of ROS and DNA damage; addition of exogenous αKG rescues the repressive histone methylation; knockdown of IDH1 increases repressive histone methylation at E2F target genes. Related to Figure 5.
Figure S1 from Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma
Authors: Zhang Xiaomeng , Tang Jian Zhong , Vergara Ismael A. , Zhang Youfang , Szeto Pacman , Yang Lie , Mintoff Christopher , Colebatch Andrew , McIntosh Lachlan , Mitchell Katrina A. , Shaw Evangeline , Rizos Helen , Long Georgina V. , Hayward Nicholas , McArthur Grant A. , Papenfuss Anthony T. , Harvey Kieran F. , Shackleton Mark
Published: April 2023

Expression of YAP, pYAP or TAZ proteins in 10 melanoma cell lines
Figure S5 from Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer
Authors: Dahl Erika S. , Buj Raquel , Leon Kelly E. , Newell Jordan M. , Imamura Yuka , Bitler Benjamin G. , Snyder Nathaniel W. , Aird Katherine M.
Published: April 2023

Knockdown of IDH1 induces senescence in Ovcar10 cells but does not increase SASP gene expression. Related to Figure 4.
Supplementary Table 6 from ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State
Authors: Kosti Adam , Du Liqin , Shivram Haridha , Qiao Mei , Burns Suzanne , Garcia Juan Gabriel , Pertsemlidis Alexander , Iyer Vishwanath R. , Kokovay Erzsebet , Penalva Luiz O.F.
Published: April 2023

Table S6. Overlap between miR-124 targets and siELF4 down-regulated genes.
Supplementary Table 5 from ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State
Authors: Kosti Adam , Du Liqin , Shivram Haridha , Qiao Mei , Burns Suzanne , Garcia Juan Gabriel , Pertsemlidis Alexander , Iyer Vishwanath R. , Kokovay Erzsebet , Penalva Luiz O.F.
Published: April 2023

Table S5. miR-124 target list (mNSC Study and miRTarBase).
Figure S3 from β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3–N-Glycan Complex
Authors: Kariya Yukiko , Oyama Midori , Hashimoto Yasuhiro , Gu Jianguo , Kariya Yoshinobu
Published: April 2023

Expression of galectin-3 in WT-Î²4-integrin expressing MDA-MB435S cells treated with galectin-3 shRNA or control shRNA.
Figure S1 from β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3–N-Glycan Complex
Authors: Kariya Yukiko , Oyama Midori , Hashimoto Yasuhiro , Gu Jianguo , Kariya Yoshinobu
Published: April 2023

Expression of bisecting GlcNAc in MDA-MB435S transfectants.
Table S1 from Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity
Authors: Edahiro Keitaro , Iimori Makoto , Kobunai Takashi , Morikawa-Ichinose Tomomi , Miura Daisuke , Kataoka Yuki , Niimi Shinichiro , Wakasa Takeshi , Saeki Hiroshi , Oki Eiji , Kitao Hiroyuki , Maehara Yoshihiko
Published: April 2023

The analyzed data from RNA-seq (SRP135850) about 97 genes categorized as "Pyrimidine metabolism"
Supplementary information from Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity
Authors: Edahiro Keitaro , Iimori Makoto , Kobunai Takashi , Morikawa-Ichinose Tomomi , Miura Daisuke , Kataoka Yuki , Niimi Shinichiro , Wakasa Takeshi , Saeki Hiroshi , Oki Eiji , Kitao Hiroyuki , Maehara Yoshihiko
Published: April 2023

Materials and methods for the supplementary figures.
Figure S4 from Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity
Authors: Edahiro Keitaro , Iimori Makoto , Kobunai Takashi , Morikawa-Ichinose Tomomi , Miura Daisuke , Kataoka Yuki , Niimi Shinichiro , Wakasa Takeshi , Saeki Hiroshi , Oki Eiji , Kitao Hiroyuki , Maehara Yoshihiko
Published: April 2023

Stability of the TS ternary complex in DLD1 and DLD1-FTD cells.
Supplementary Table S1 from O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors
Authors: Efimova Elena V. , Appelbe Oliver K. , Ricco Natalia , Lee Steve S.-Y. , Liu Yue , Wolfgeher Donald J. , Collins Tamica N. , Flor Amy C. , Ramamurthy Aishwarya , Warrington Sara , Bindokas Vytautas P. , Kron Stephen J.
Published: April 2023

O-GlcNAc proteomic hits of significance
Figure S2 from Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity
Authors: Edahiro Keitaro , Iimori Makoto , Kobunai Takashi , Morikawa-Ichinose Tomomi , Miura Daisuke , Kataoka Yuki , Niimi Shinichiro , Wakasa Takeshi , Saeki Hiroshi , Oki Eiji , Kitao Hiroyuki , Maehara Yoshihiko
Published: April 2023

The effect of siRNA against TK1 and TK2 on FTD activation.
Supplementary Table S1 from Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression
Authors: Gowda Pramod S. , Wildman Benjamin J. , Trotter Timothy N. , Xu Xiaoxuan , Hao Xiaoxiao , Hassan Mohammad Q. , Yang Yang
Published: April 2023

Primers for Real-time qPCR.
Supplementary Figures 1 - 3 from A TAZ–ANGPTL4–NOX2 Axis Regulates Ferroptotic Cell Death and Chemoresistance in Epithelial Ovarian Cancer
Authors: Yang Wen-Hsuan , Huang Zhiqing , Wu Jianli , Ding Chien-Kuang C. , Murphy Susan K. , Chi Jen-Tsan
Published: April 2023

Supplementary Figures 1 - 3
Supplementary Figure 3 from LINC00152 Promotes Invasion through a 3′-Hairpin Structure and Associates with Prognosis in Glioblastoma
Authors: Reon Brian J. , Takao Real Karia Bruno , Kiran Manjari , Dutta Anindya
Published: April 2023

Expression of genes involved in EMT are decreased by si LINC00152 rescued by LINC00152 m8 overexpression. A-G) qRT-PCR showing (A) LINC00152, (B) TPM2, (C) PTX3, (D) IGFBP4, (E) TGM2, (F) SPP1, (G) LUM expression after siGL2 and pcDNA3, or siLINC00152_II and pcDNA3, or siLINC00152_II and LINC00152 m8 transfections.
Supplementary Table S1 from Expression Profiling of Circulating Microvesicles Reveals Intercellular Transmission of Oncogenic Pathways
Authors: Milani Gloria , Lana Tobia , Bresolin Silvia , Aveic Sanja , Pastò Anna , Frasson Chiara , te Kronnie Geertruy
Published: April 2023

Gene sets enriched in the "oncogenic transcript family"resulted by GSEA analyses (C6 MSigDatabase) on K562 cells and K562 MVs common transcripts.
Supplementary Figure S5 from Expression Profiling of Circulating Microvesicles Reveals Intercellular Transmission of Oncogenic Pathways
Authors: Milani Gloria , Lana Tobia , Bresolin Silvia , Aveic Sanja , Pastò Anna , Frasson Chiara , te Kronnie Geertruy
Published: April 2023

K562 cells - K562 MVs co-culture.
Table S1 from TRPM7 Regulates AKT/FOXO1–Dependent Tumor Growth and Is an Independent Prognostic Indicator in Renal Cell Carcinoma
Authors: Zhao Zhijian , Zhang Mengping , Duan Xiaolu , Chen Yiwen , Li Ermao , Luo Lianmin , Wu Wenqi , Peng Zhenwei , Qiu Huijuan , Zeng Guohua
Published: April 2023

Table S1: Univariate and multivariate cox regression analyses for overall survival and progression-free survival in non-metastasis ccRCC patients
Supplementary Fig. S5 from Paracrine Interaction of Cancer Stem Cell Populations Is Regulated by the Senescence-Associated Secretory Phenotype (SASP)
Authors: Lagunas Angelica M. , Francis Marybeth , Maniar Nisha B. , Nikolova Gergana , Wu Jianchun , Crowe David L.
Published: April 2023

PI3K signaling is the primary mediator of the effects of cancer stem cell chemokines on SCC.
Supplementary Fig. S4 from Paracrine Interaction of Cancer Stem Cell Populations Is Regulated by the Senescence-Associated Secretory Phenotype (SASP)
Authors: Lagunas Angelica M. , Francis Marybeth , Maniar Nisha B. , Nikolova Gergana , Wu Jianchun , Crowe David L.
Published: April 2023

Loss of Cxcr2 signaling inhibits multiple intracellular signaling pathways in SCC.
Supplementary Figure S3 from Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia
Authors: Gassner Franz Josef , Schubert Maria , Rebhandl Stefan , Spandl Karina , Zaborsky Nadja , Catakovic Kemal , Blaimer Stephanie , Hebenstreit Daniel , Greil Richard , Geisberger Roland
Published: April 2023

Cell cycle analysis of CLL and B cells. Purified B and CLL cells are stained for CD5, CD19 and DNA content (vybrant dye). The gating strategy for flow cytometry is shown for B (A) and CLL cells (B). (C) The graph shows mean+SD for cells in G1, S and G2/M phase of the cell cycle (CLL n=7; B cells n=5)
Supplementary Figure S2 from Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia
Authors: Gassner Franz Josef , Schubert Maria , Rebhandl Stefan , Spandl Karina , Zaborsky Nadja , Catakovic Kemal , Blaimer Stephanie , Hebenstreit Daniel , Greil Richard , Geisberger Roland
Published: April 2023

Microhomologies within repair junctions from substrate #7 in CLL and B cells. The most frequent sequences (frequency >100) are aligned and microhomologies given as colored letters. ssDNA overhangs are marked by colored areas.
Table S1 from Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer
Authors: Hu Wangxiong , Yang Yanmei , Li Xiaofen , Huang Minran , Xu Fei , Ge Weiting , Zhang Suzhan , Zheng Shu
Published: April 2023

FMGS identified in LCC and RCC
Supplementary Figure S1 from Leptin Signaling Mediates Obesity-Associated CSC Enrichment and EMT in Preclinical TNBC Models
Authors: Bowers Laura W. , Rossi Emily L. , McDonell Shannon B. , Doerstling Steven S. , Khatib Subreen A. , Lineberger Claire G. , Albright Jody E. , Tang Xiaohu , deGraffenried Linda A. , Hursting Stephen D.
Published: April 2023

Body weight and percent body fat of MMTV-Wnt-1 mice.
Table S3 from BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism
Authors: Vázquez-Arreguín Karina , Maddox Jessica , Kang Jinsuk , Park Dongju , Cano Reuben R. , Factor Rachel E. , Ludwig Thomas , Tantin Dean
Published: April 2023

RNAseq analysis of dysregulated genes from Oct1-KO and control BRCA1-I26A MEFs.
Supplementary Figure S4 from Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer
Authors: Takayama Ken-ichi , Suzuki Takashi , Fujimura Tetsuya , Takahashi Satoru , Inoue Satoshi
Published: April 2023

Supplementary Figure S4. Overexpression of USP10 increased cell growth of LNCaP and 22Rv1 cells.
Table S2 from BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism
Authors: Vázquez-Arreguín Karina , Maddox Jessica , Kang Jinsuk , Park Dongju , Cano Reuben R. , Factor Rachel E. , Ludwig Thomas , Tantin Dean
Published: April 2023

RNAseq gene expression changes in BRCA1-I26A mutant MEFs (Oct1 CRISPR vs control).
Supplementary Figure 2 from Epigenetic Regulation of Dlg1, via Kaiso, Alters Mitotic Spindle Polarity and Promotes Intestinal Tumorigenesis
Authors: Young Madeleine A. , May Stephanie , Damo Angelos , Yoon Young So , Hur Man-Wook , Swat Wojiech , Parry Lee
Published: April 2023

(A&B) Dlg1 and Dlgap1 promoter regions contain Kaiso binding sequences. The region 5kb upstream of the Dlg1 exon 1 (NR_045516) and Dlgap1 (NM_177639), Kaiso binding domains ((full -TTCCTGCNA (red) & minimum-CTGCNA (green)) and CGCG (blue). Primers locations used for ChIP analysis are indicated in yellow.
Supplemental Data from Epigenetic Regulation of Dlg1, via Kaiso, Alters Mitotic Spindle Polarity and Promotes Intestinal Tumorigenesis
Authors: Young Madeleine A. , May Stephanie , Damo Angelos , Yoon Young So , Hur Man-Wook , Swat Wojiech , Parry Lee
Published: April 2023

Supplemental Legends
Supplementary Table 3 from Adaptive Protein Translation by the Integrated Stress Response Maintains the Proliferative and Migratory Capacity of Lung Adenocarcinoma Cells
Authors: Albert Alexandra E. , Adua Sally J. , Cai Wesley L. , Arnal-Estapé Anna , Cline Gary W. , Liu Zongzhi , Zhao Minghui , Cao Paul D. , Mariappan Malaiyalam , Nguyen Don X.
Published: April 2023

Supplementary Table 3 lists the results of Pathway analysis of differential gene expression in LUAD cells treated with ISRIB during asparagine deprivation.
Supplementary Table 2 from Adaptive Protein Translation by the Integrated Stress Response Maintains the Proliferative and Migratory Capacity of Lung Adenocarcinoma Cells
Authors: Albert Alexandra E. , Adua Sally J. , Cai Wesley L. , Arnal-Estapé Anna , Cline Gary W. , Liu Zongzhi , Zhao Minghui , Cao Paul D. , Mariappan Malaiyalam , Nguyen Don X.
Published: April 2023

Supplementary Table 2 shows differential gene expression in LUAD cells treated with ISRIB during asparagine deprivation.
Figure S4 from Adaptive Protein Translation by the Integrated Stress Response Maintains the Proliferative and Migratory Capacity of Lung Adenocarcinoma Cells
Authors: Albert Alexandra E. , Adua Sally J. , Cai Wesley L. , Arnal-Estapé Anna , Cline Gary W. , Liu Zongzhi , Zhao Minghui , Cao Paul D. , Mariappan Malaiyalam , Nguyen Don X.
Published: April 2023

This figure shows that ASNS mediates protein translation during amino acid deprivation.
Figure S1 from Adaptive Protein Translation by the Integrated Stress Response Maintains the Proliferative and Migratory Capacity of Lung Adenocarcinoma Cells
Authors: Albert Alexandra E. , Adua Sally J. , Cai Wesley L. , Arnal-Estapé Anna , Cline Gary W. , Liu Zongzhi , Zhao Minghui , Cao Paul D. , Mariappan Malaiyalam , Nguyen Don X.
Published: April 2023

This figure demonstrates that the ISR is activated in diverse molecular subtypes and stages of LUAD and can be inhibited by ISRIB.
Figure S7 from Deciphering the Role of Protein Kinase D1 (PKD1) in Cellular Proliferation
Authors: Youssef Ilige , Ricort Jean-Marc
Published: April 2023

mRNA level of PKD1 expression from melanoma TCGA data
Supplementary Figure S4 from Cortactin Phosphorylation by Casein Kinase 2 Regulates Actin-Related Protein 2/3 Complex Activity, Invadopodia Function, and Tumor Cell Invasion
Authors: Markwell Steven M. , Ammer Amanda G. , Interval Erik T. , Allen Jessica L. , Papenberg Brenen W. , Hames River A. , Castaño Johnathan E. , Schafer Dorothy A. , Weed Scott A.
Published: April 2023

Quantitation of collective groups in control and drug treated orthotopic tongue tumors.
Supplementary Figures 1-2, Supplementary Tables 1-3 from The FGFR1 V561M Gatekeeper Mutation Drives AZD4547 Resistance through STAT3 Activation and EMT
Authors: Ryan Molly R. , Sohl Christal D. , Luo BeiBei , Anderson Karen S.
Published: April 2023

Figure S1: qPCR of FGF2 mRNA expression in H1581 and L6 cells Figure S2: STAT3 knockdown sensitizes H1581-V561M cells to AZD4547 treatment. Table S1 and S2: Proliferation after various timepoints Table S3: AZD4547 sensitivity of L6 shRNA-treated cells
Figure S5 from AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers
Authors: Tolza Claire , Bejjani Fabienne , Evanno Emilie , Mahfoud Samantha , Moquet-Torcy Gabriel , Gostan Thierry , Maqbool Muhammad Ahmad , Kirsh Olivier , Piechaczyk Marc , Jariel-Encontre Isabelle
Published: April 2023

Binding of AP-1 proteins to the HMGA1 locus in MDA-MB-231 cells after alteration of Fra-1 or Fra-2 levels
Figure S2 from AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers
Authors: Tolza Claire , Bejjani Fabienne , Evanno Emilie , Mahfoud Samantha , Moquet-Torcy Gabriel , Gostan Thierry , Maqbool Muhammad Ahmad , Kirsh Olivier , Piechaczyk Marc , Jariel-Encontre Isabelle
Published: April 2023

Fra-1 regulates HMGA1 expression
Figure S3 from Desmoglein 1 Regulates Invadopodia by Suppressing EGFR/Erk Signaling in an Erbin-Dependent Manner
Authors: Valenzuela-Iglesias Alejandra , Burks Hope E. , Arnette Christopher R. , Yalamanchili Amulya , Nekrasova Oxana , Godsel Lisa M. , Green Kathleen J.
Published: April 2023

Supplemental Figure 3: Quantification of invadopodial matrix degradation per invadopodium.
Supplementary Figures from Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade
Authors: Gong Yixuan , Wang Li , Yu Haocheng , Alpert Naomi , Cohen Mitchell D. , Prophete Colette , Horton Lori , Sisco Maureen , Park Sung-Hyun , Lee Hyun-Wook , Zelikoff Judith , Chen Lung-Chi , Hashim Dana , Suarez-Farinas Mayte , Donovan Michael J. , Aaronson Stuart A. , Galsky Matthew , Zhu Jun , Taioli Emanuela , Oh William K.
Published: April 2023

Supplementary Figures 1-3
Supplemental Table 1 from TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent
Authors: Hedrick Erik , Mohankumar Kumaravel , Safe Stephen
Published: April 2023

Antibodies and their sources.
Supplemental Figure 2 from TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent
Authors: Hedrick Erik , Mohankumar Kumaravel , Safe Stephen
Published: April 2023

Confocal microscopic analysis of kinase-induced nuclear export of NR4A1.
Table S4 from Population-dependent Intron Retention and DNA Methylation in Breast Cancer
Authors: Kim Dongwook , Shivakumar Manu , Han Seonggyun , Sinclair Michael S. , Lee Young-Ji , Zheng Yonglan , Olopade Olufunmilayo I. , Kim Dokyoon , Lee Younghee
Published: April 2023

Forty methylation sites and their corresponding SNPs
Supplementary Table 2 from SIX1 Regulates Aberrant Endometrial Epithelial Cell Differentiation and Cancer Latency Following Developmental Estrogenic Chemical Exposure
Authors: Suen Alisa A. , Jefferson Wendy N. , Wood Charles E. , Williams Carmen J.
Published: April 2023

Table S2A: 2,856 DEGs CON-Six1d/d versus CON-Six1+/+ Table S2B: GO Categories from 2,856 DEGs CON-Six1d/d versus CON-Six1+/+ Table S2C: NextBio Bioset overlap with KO Atlas from 2,856 DEGs CON-Six1d/d versus CON-Six1+/+ Table S2D: NextBio Bioset overlap with IHH bioset from 2,856 DEGs CON-Six1d/d versus CON-Six1+/+ Table S2E: 993 DEGs DES-Six1d/d versus DES-Six1+/+ Table S2F: GO Categories from 993 DEGs DES-Six1d/d versus DES-Six1+/+ Table S2G: NextBio Bioset overlap with KO Atlas from 993 DEGs DES-Six1d/d versus DES-Six1+/+ Table S2H: NextBio Bioset overlap with PTEN bioset from 993 DEGs DES-Six1d/d versus DES-Six1+/+ Table S2I: EPIG protection pattern with 585 DEGs Table S2J: EPIG protection pattern with 585 DEGs GO categories
Table S1 from Population-dependent Intron Retention and DNA Methylation in Breast Cancer
Authors: Kim Dongwook , Shivakumar Manu , Han Seonggyun , Sinclair Michael S. , Lee Young-Ji , Zheng Yonglan , Olopade Olufunmilayo I. , Kim Dokyoon , Lee Younghee
Published: April 2023

Stratification of the genetic ancestry of the breast cancer patients
Supplementary Table 1 from SIX1 Regulates Aberrant Endometrial Epithelial Cell Differentiation and Cancer Latency Following Developmental Estrogenic Chemical Exposure
Authors: Suen Alisa A. , Jefferson Wendy N. , Wood Charles E. , Williams Carmen J.
Published: April 2023

Supplementary Table S1. Antibodies used for immunohistochemistry and immunofluorescence
Figure S3 from Population-dependent Intron Retention and DNA Methylation in Breast Cancer
Authors: Kim Dongwook , Shivakumar Manu , Han Seonggyun , Sinclair Michael S. , Lee Young-Ji , Zheng Yonglan , Olopade Olufunmilayo I. , Kim Dokyoon , Lee Younghee
Published: April 2023

Protein-protein interaction network of breast cancer
Supplementary Figures S1-4 from SIX1 Regulates Aberrant Endometrial Epithelial Cell Differentiation and Cancer Latency Following Developmental Estrogenic Chemical Exposure
Authors: Suen Alisa A. , Jefferson Wendy N. , Wood Charles E. , Williams Carmen J.
Published: April 2023

Supplementary Figure S1. Six1 transcript and protein expression in Six 1conditional knockout mice following neonatal DES exposure. Supplementary Figure S2. Supplementary Figure S3. Supplementary Figure S4. CK14/18 staining in normal and abnormal uterine epithelium.
Supplemental Table 5 from Epigenetic Targeting of Adipocytes Inhibits High-Grade Serous Ovarian Cancer Cell Migration and Invasion
Authors: Tang Jessica , Pulliam Nicholas , Özeş Ali , Buechlein Aaron , Ding Ning , Keer Harold , Rusch Doug , O'Hagan Heather , Stack M. Sharon , Nephew Kenneth P.
Published: April 2023

Mecap-Seq hypomethylated, hypermethylated genes that were also upregulated, downregulated, respectively in RNA-seq
Supplementary Figures 1-7 from Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer
Authors: Basudan Ahmed , Priedigkeit Nolan , Hartmaier Ryan J. , Sokol Ethan S. , Bahreini Amir , Watters Rebecca J. , Boisen Michelle M. , Bhargava Rohit , Weiss Kurt R. , Karsten Maria M. , Denkert Carsten , Blohmer Jens-Uwe , Leone Jose P. , Hamilton Ronald L. , Brufsky Adam M. , Elishaev Esther , Lucas Peter C. , Lee Adrian V. , Oesterreich Steffi
Published: April 2023

Figure S1: Genomic organization of ESR1 nanoString probes Figure S2: Correlation of ESR1 amplification with mRNA expression Figure S3: ESR1 copy number status in ER+ primary-metastasis pairs Figure S4: Oncoprint visualization of copy number alterations in clinical samples Figure S5: eSNP-Karyotyping analysis of ERBB2 amplified samples Figure S6: Oncoprint visualization of copy number alterations in ER+ vs ER+ brain metastases Figure S7: Oncoprint visualization of copy number alterations in paired primary-met samples
Supplementary Data File 6 from GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer
Authors: Bevill Samantha M. , Olivares-Quintero Jose F. , Sciaky Noah , Golitz Brian T. , Singh Darshan , Beltran Adriana S. , Rashid Naim U. , Stuhlmiller Timothy J. , Hale Andrew , Moorman Nathaniel J. , Santos Charlene M. , Angus Steven P. , Zawistowski Jon S. , Johnson Gary L.
Published: April 2023

File contains enrichment scores and p-values for gene sets evaluated using GSEA for RNA sequencing data sets
Supplementary Table S4 from A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance
Authors: Olender Jacqueline , Wang Bi-Dar , Ching Travers , Garmire Lana X. , Garofano Kaitlin , Ji Youngmi , Knox Tessa , Latham Patricia , Nguyen Kenneth , Rhim Johng , Lee Norman H.
Published: April 2023

Supplemental Table S4. IC50 values calculated for proliferation, migration, and invasion assays for PC-3 and LNCaP overexpressing cell lines from Fig 3.
Supplementary Data File 5 from GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer
Authors: Bevill Samantha M. , Olivares-Quintero Jose F. , Sciaky Noah , Golitz Brian T. , Singh Darshan , Beltran Adriana S. , Rashid Naim U. , Stuhlmiller Timothy J. , Hale Andrew , Moorman Nathaniel J. , Santos Charlene M. , Angus Steven P. , Zawistowski Jon S. , Johnson Gary L.
Published: April 2023

File includes AlphaScreening values for activity of the screening library against the BET or p300 bromodomains
Supplementary Table S2 from A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance
Authors: Olender Jacqueline , Wang Bi-Dar , Ching Travers , Garmire Lana X. , Garofano Kaitlin , Ji Youngmi , Knox Tessa , Latham Patricia , Nguyen Kenneth , Rhim Johng , Lee Norman H.
Published: April 2023

Supplemental Table S2. Relative phospho-protein expression with and without FGF2 treatment.
Supplementary Table S1 from A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance
Authors: Olender Jacqueline , Wang Bi-Dar , Ching Travers , Garmire Lana X. , Garofano Kaitlin , Ji Youngmi , Knox Tessa , Latham Patricia , Nguyen Kenneth , Rhim Johng , Lee Norman H.
Published: April 2023

Supplemental Table S1. Primer sequences used for 5' and 3' RACE of FGFR3 variant.
Supplementary Figures S1 - S6, Tables S1 - S2 from Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature
Authors: Singhal Udit , Wang Yugang , Henderson James , Niknafs Yashar S. , Qiao Yuanyuan , Gursky Amy , Zaslavsky Alexander , Chung Jae-Seung , Smith David C. , Karnes R. Jeffrey , Chang S. Laura , Feng Felix Y. , Palapattu Ganesh S. , Taichman Russell S. , Chinnaiyan Arul M. , Tomlins Scott A. , Morgan Todd M.
Published: April 2023

Supplementary Figure S1: Evaluation of pre-amplication. Supplementary Figure S2: Algorithm for CTC positivity. Supplementary Figure S3: CTC isolation and gene analysis methodology. Supplementary Figure S4: Validation of gene expression. Supplementary Figure S5: CTC status is not predictive of overall survival. Supplementary Figure S6: miCTC score flowsheet. Supplementary Table 1: primer tables. Supplementary Table 2: Ct values.
Supplementary Data from Lipid Uptake Is an Androgen-Enhanced Lipid Supply Pathway Associated with Prostate Cancer Disease Progression and Bone Metastasis
Authors: Tousignant Kaylyn D. , Rockstroh Anja , Taherian Fard Atefeh , Lehman Melanie L. , Wang Chenwei , McPherson Stephen J. , Philp Lisa K. , Bartonicek Nenad , Dinger Marcel E. , Nelson Colleen C. , Sadowski Martin C.
Published: April 2023

Supplementary Figures
Table S2 from Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression
Authors: Kulkarni Priyanka , Dasgupta Pritha , Bhat Nadeem S. , Shahryari Varahram , Shiina Marisa , Hashimoto Yutaka , Majid Shahana , Deng Guoren , Saini Sharanjot , Tabatabai Z. Laura , Yamamura Soichiro , Tanaka Yuichiro , Dahiya Rajvir
Published: April 2023

Table S2 is for Patient Characteristics
Supplementary Data from Insight into the Etiology of Undifferentiated Soft Tissue Sarcomas from a Novel Mouse Model
Authors: Fleming Jonathan T. , Brignola Emily , Chen Lei , Guo Yan , Zhao Shilin , Wang Quan , Li Bingshan , Correa Hernán , Ermilov Alexandre N. , Dlugosz Andrzej A. , Chiang Chin
Published: April 2023

Figure S1. PCG2 tumors showed persistent Hh pathway activity, while SmoM2 disrupts brain morphogenesis. Figure S2. PCG2 gene expression and ultrastructural features. Figure S3. Characterization of PCG2M226 cells. Figure S4. Phenotypic divergence between PCG2; Gli1nlacZ and PCG2 tumors. Figure S5. Fate-mapping of Pcp2-cre lineage cells.
Supplementary Figure S4 from PTEN Regulates Nonhomologous End Joining By Epigenetic Induction of NHEJ1/XLF
Authors: Sulkowski Parker L. , Scanlon Susan E. , Oeck Sebastian , Glazer Peter M.
Published: April 2023

Additional Data on XLF Promoter Activity and Occupancy
Supplementary Materials and Methods, Figure Legends from Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel
Authors: Breed Christopher , Hicks Douglas A. , Webb Patricia G. , Galimanis Carly E. , Bitler Benjamin G. , Behbakht Kian , Baumgartner Heidi K.
Published: April 2023

Supplementary Materials and Methods, Figure Legends from Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel
Supplementary Figure 2 from Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel
Authors: Breed Christopher , Hicks Douglas A. , Webb Patricia G. , Galimanis Carly E. , Bitler Benjamin G. , Behbakht Kian , Baumgartner Heidi K.
Published: April 2023

Apoptotic response of cells with high and low claudin-4 expression.
Supplementary Figure 1 from Ovarian Tumor Cell Expression of Claudin-4 Reduces Apoptotic Response to Paclitaxel
Authors: Breed Christopher , Hicks Douglas A. , Webb Patricia G. , Galimanis Carly E. , Bitler Benjamin G. , Behbakht Kian , Baumgartner Heidi K.
Published: April 2023

Claudin-4 expression in patient tumors.
Supplementary Table 2 from Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy
Authors: Octeau David , Kessous Roy , Klein Kathleen , Kogan Liron , Pelmus Manuella , Ferenczy Alex , Greenwood Celia M.T. , Van Kempen Leon C. , Salvador Shannon , Lau Susie , Tonin Patricia N. , Yasmeen Amber , Gotlieb Walter H.
Published: April 2023

Mutation list
Supplementary Table 1 from Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant Chemotherapy
Authors: Octeau David , Kessous Roy , Klein Kathleen , Kogan Liron , Pelmus Manuella , Ferenczy Alex , Greenwood Celia M.T. , Van Kempen Leon C. , Salvador Shannon , Lau Susie , Tonin Patricia N. , Yasmeen Amber , Gotlieb Walter H.
Published: April 2023

Patient characteristics
Supplementary Table S3 from Nomogram Integrating Genomics with Clinicopathologic Features Improves Prognosis Prediction for Colorectal Cancer
Authors: Xiong Yongfu , You Wenxian , Hou Min , Peng Linglong , Zhou He , Fu Zhongxue
Published: April 2023

Description of the 27 CRC prognosis-related signatures included in this study
Supplementary Table S1 from Nomogram Integrating Genomics with Clinicopathologic Features Improves Prognosis Prediction for Colorectal Cancer
Authors: Xiong Yongfu , You Wenxian , Hou Min , Peng Linglong , Zhou He , Fu Zhongxue
Published: April 2023

Characteristics of patients included in the study
Supplemental Figures 1-7 from Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations
Authors: Lehmann Brian D. , Shaver Timothy M. , Johnson Douglas B. , Li Zhu , Gonzalez-Ericsson Paula I. , Sánchez Violeta , Shyr Yu , Sanders Melinda E. , Pietenpol Jennifer A.
Published: April 2023

Fig S1. Frequent focal amplification of DNA proximal to MAP3K8 breakpoint from TCGA tumors and overall survival. Fig S2. Breakpoint spanning reads and resulting protein translation from additional TCGA melanoma tumors with MAP3K8 rearrangements. Fig S3. Exogenous expression of full length and truncated MAP3K8 decrease sensitivity of BRAF-mutated cells. Fig S4. Identification of additional potential cell line models with MAP3K8 truncating rearrangements. Fig S5. Viability selectively decreased upon MAP3K8 siRNA knockdown in cells harboring truncating MAP3K8 rearrangements. Fig S6. Differential gene expression analysis identifies pathways enriched in MAP3K8-truncated melanomas. Fig S7. Break-apart FISH scoring of melanoma tissue microarray identifies rearranged and amplified MAP3K8.
Supplemental Figure Legends from Identification of Targetable Recurrent MAP3K8 Rearrangements in Melanomas Lacking Known Driver Mutations
Authors: Lehmann Brian D. , Shaver Timothy M. , Johnson Douglas B. , Li Zhu , Gonzalez-Ericsson Paula I. , Sánchez Violeta , Shyr Yu , Sanders Melinda E. , Pietenpol Jennifer A.
Published: April 2023

Supplemental Figure Legends 1-7
Supplementary Data from BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK
Authors: Shafran Jordan S. , Andrieu Guillaume P. , Györffy Balázs , Denis Gerald V.
Published: April 2023

Supplementary Figure and Table Legends
Supplementary Figures 1-5 from ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties
Authors: Childress Merrida A. , Himmelberg Stephen M. , Chen Huiqin , Deng Wanleng , Davies Michael A. , Lovly Christine M.
Published: April 2023

S1. Expression of ALK fusion variants. S2. Active ALK variants change the protein expression profile of NIH3T3 cells. S3. ALK fusion variants exhibit differential response to ALK TKIs. S4. Immunoprecipitated ALK fusion variants for kinase assays S5. ALK fusion variants exhibit differences in protein turnover and sensitivity to ganetespib.
Supplementary Video 2 from Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer
Authors: Tracy Kirsten M. , Tye Coralee E. , Ghule Prachi N. , Malaby Heidi L.H. , Stumpff Jason , Stein Janet L. , Stein Gary S. , Lian Jane B.
Published: April 2023

Live cell imaging of MANCR ASO_2.
Supplementary Video 1 from Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer
Authors: Tracy Kirsten M. , Tye Coralee E. , Ghule Prachi N. , Malaby Heidi L.H. , Stumpff Jason , Stein Janet L. , Stein Gary S. , Lian Jane B.
Published: April 2023

Live cell imaging of Control ASO.
Supplementary Table 1 from Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer
Authors: Tracy Kirsten M. , Tye Coralee E. , Ghule Prachi N. , Malaby Heidi L.H. , Stumpff Jason , Stein Janet L. , Stein Gary S. , Lian Jane B.
Published: April 2023

RT-qPCR primer sequences.
Supplementary Figure 4 from Mitotically-Associated lncRNA (MANCR) Affects Genomic Stability and Cell Division in Aggressive Breast Cancer
Authors: Tracy Kirsten M. , Tye Coralee E. , Ghule Prachi N. , Malaby Heidi L.H. , Stumpff Jason , Stein Janet L. , Stein Gary S. , Lian Jane B.
Published: April 2023

MANCR depletion does not affect timing of anaphase onset.
Supplementary figures from PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways
Authors: Zhao Yulei , Montminy Tess , Azad Taha , Lightbody Elizabeth , Hao Yawei , SenGupta Sandip , Asselin Eric , Nicol Christopher , Yang Xiaolong
Published: April 2023

Figure. 1 PIK3CB positively regulates TAZ. S-Figure. 2 Quantitation of subcellular localization of YAP and TAZ. S-Figure 3. PDK1 regulates LATS-YAP/TAZ through its kinase activity. S-Figure 4. No direct regulations between LATS and AKT. S-Fig. 5 AKT1 positively regulates YAP expression which is involved in YAP-LATS negative feedback. S-Figure 6. A-B. YAP and TAZ were knocked out through CRISPR system in MCF10A-PIK3CB or PIK3CA-H1047R cells
Supplementary Tables S1 - S2 from BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
Authors: Andrieu Guillaume P. , Denis Gerald V.
Published: April 2023

Supplementary Table 1 indicates the primers sequences used for this study. Supplementary Table 2 describes the list of the EMT genes co-regulated by BET proteins.
Supplementary Figure S2 from BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
Authors: Andrieu Guillaume P. , Denis Gerald V.
Published: April 2023

Differential control of key EMT transcription factors by BET proteins. (A-B) mRNA expression of key EMT transcription factors upon BET protein depletion in SUM149PT cells (50 nM for three days) (A) or BET protein overexpression for three days in T47D cells (B). C, mRNA expression of key EMT transcription factors upon pan-BET inhibition with JQ1 (400 nM for three days). Histograms represent means {plus minus} SEM of three independent experiments. Statistical analyses were conducted by one-way ANOVA. The following symbols were used to indicate significant differences: ns, P > 0.05; **, P < 0.01; ***, P < 0.001.
Supplementary Figure S1 from BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
Authors: Andrieu Guillaume P. , Denis Gerald V.
Published: April 2023

Distinct EMT transcriptomes are attributable to each BET protein in breast cancer cells. A-B, Heatmap presenting Z scores of a PCR array of 84 EMT genes expressed upon BET protein depletion (50 nM for three days) in SUM149PT (n=3) (A), or MCF-7 cells (n=2) (B). C, Heatmap presenting Z scores of the PCR array upon BET protein overexpression in MCF-7 cells for three days (n=3). A color code is used to illustrate Z score variations. Normalization is set to scramble.
Supplementary Figure Legends from BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
Authors: Andrieu Guillaume P. , Denis Gerald V.
Published: April 2023

Supplementary Figure Legends from BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
Table S1-2, Figure S1-4 from CHP2 Promotes Cell Proliferation in Breast Cancer via Suppression of FOXO3a
Authors: Zhao Xiaohui , Xie Tian , Dai Ting , Zhao Wenhui , Li Jing , Xu Rui , Jiang Chao , Li Peiqiong , Deng Junyao , Su Xiaobo , Ma Ningfang
Published: April 2023

Table S1-2 and Figure S1-4 show that CHP2 was upregulated in breast cancer cells.
Supplementary Table S1 from Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/CCDH1 Activity and Pharmacologic Inhibition of APC/CCDH1/CDC20 Compromises Viability
Authors: De Kuntal , Grubb Treg M. , Zalenski Abigail A. , Pfaff Kayla E. , Pal Debjani , Majumder Shubhra , Summers Matthew K. , Venere Monica
Published: April 2023

Pathological and cytogenetic characteristics for the specimens evaluated
Supplementary Figures S1 - S10 from AR Expression in Breast Cancer CTCs Associates with Bone Metastases
Authors: Aceto Nicola , Bardia Aditya , Wittner Ben S. , Donaldson Maria C. , O'Keefe Ryan , Engstrom Amanda , Bersani Francesca , Zheng Yu , Comaills Valentine , Niederhoffer Kira , Zhu Huili , Mackenzie Olivia , Shioda Toshi , Sgroi Dennis , Kapur Ravi , Ting David T. , Moy Beverly , Ramaswamy Sridhar , Toner Mehmet , Haber Daniel A. , Maheswaran Shyamala
Published: April 2023

Supplementary Figure S1: RNA sequencing and pathway analysis of CTCs from Bone(+) versus Visceral(+) breast cancer patients. Supplementary Figure S2: Correlation between AR expression and AR signatures. Supplementary Figure S3: ER and PR expression in CTCs from Bone(+) versus Visceral(+) breast cancer patients. Supplementary Figure S4: AR antibody validation. Supplementary Figure S5: AR copy number assessment in breast cancer bone metastasis. Supplementary Figure S6: ER and PR expression in primary and metastatic breast cancer. Supplementary Figure S7: AR expression correlates with bone metastasis independently of ER status. Supplementary Figure S8: Enzalutamide treatment induces downregulation of a subset of AR-dependent genes in breast cancer cells. Supplementary Figure S9: AR shRNA validation. Supplementary Figure S10: AR inhibition does not alter primary tumor growth.
Supplementary Figure S6 from Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/CCDH1 Activity and Pharmacologic Inhibition of APC/CCDH1/CDC20 Compromises Viability
Authors: De Kuntal , Grubb Treg M. , Zalenski Abigail A. , Pfaff Kayla E. , Pal Debjani , Majumder Shubhra , Summers Matthew K. , Venere Monica
Published: April 2023

Impact of drug treatment on normal human astrocytes
Supplementary Figure S4 from Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/CCDH1 Activity and Pharmacologic Inhibition of APC/CCDH1/CDC20 Compromises Viability
Authors: De Kuntal , Grubb Treg M. , Zalenski Abigail A. , Pfaff Kayla E. , Pal Debjani , Majumder Shubhra , Summers Matthew K. , Venere Monica
Published: April 2023

Representative confluence CSC images collected by the IncuCyte Zoom
Supplementary Figure S1 from Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/CCDH1 Activity and Pharmacologic Inhibition of APC/CCDH1/CDC20 Compromises Viability
Authors: De Kuntal , Grubb Treg M. , Zalenski Abigail A. , Pfaff Kayla E. , Pal Debjani , Majumder Shubhra , Summers Matthew K. , Venere Monica
Published: April 2023

Nocodazole synchronization for GBM CSCs
Supplementary Figures 1 and 2 from RNF8 Promotes Epithelial–Mesenchymal Transition in Lung Cancer Cells via Stabilization of Slug
Authors: Kuang Jingyu , Min Lu , Liu Chuanyang , Chen Si , Gao Changsong , Ma Jiaxin , Wu Xiaomin , Li Wenying , Wu Lei , Zhu Lingyun
Published: April 2023

Figure S1 shows the expression of RNF8 in different pathological types of lung cancers tissues. Figure S2 shows the overexpression of RNF8-C406S cannot improve the migration potential of A549 cells.
Supplementary Table S1 from Growth-Inhibitory Activity of Bone Morphogenetic Protein 4 in Human Glioblastoma Cell Lines Is Heterogeneous and Dependent on Reduced SOX2 Expression
Authors: Dalmo Erika , Johansson Patrik , Niklasson Mia , Gustavsson Ida , Nelander Sven , Westermark Bengt
Published: April 2023

Table S1. Enriched GO terms for commonly upregulated genes in responsive cell lines and U3017MG harboring the control vector upon BMP4 treatment, according to the Database for Annotation, Visualization and Integrated Discovery (DAVID).
Supplementary Table 1 and Table 2 from Anti–miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation
Authors: Wagenaar Timothy R. , Zabludoff Sonya , Ahn Sung-Min , Allerson Charles , Arlt Heike , Baffa Raffaele , Cao Hui , Davis Scott , Garcia-Echeverria Carlos , Gaur Rajula , Huang Shih-Min A. , Jiang Lan , Kim Deokhoon , Metz-Weidmann Christiane , Pavlicek Adam , Pollard Jack , Reeves Jason , Rocnik Jennifer L. , Scheidler Sabine , Shi Chaomei , Sun Fangxian , Tolstykh Tatiana , Weber William , Winter Christopher , Yu Eunsil , Yu Qunyan , Zheng Gang , Wiederschain Dmitri
Published: April 2023

Supplementary Tables 1 and 2. Supplementary Table 1: Fold de-repression of miR-21 target genes after anti-miR-21 treatment. Supplementary Table 2: Taqman Primer and Probes
Supplementary Figure Legends from Anti–miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation
Authors: Wagenaar Timothy R. , Zabludoff Sonya , Ahn Sung-Min , Allerson Charles , Arlt Heike , Baffa Raffaele , Cao Hui , Davis Scott , Garcia-Echeverria Carlos , Gaur Rajula , Huang Shih-Min A. , Jiang Lan , Kim Deokhoon , Metz-Weidmann Christiane , Pavlicek Adam , Pollard Jack , Reeves Jason , Rocnik Jennifer L. , Scheidler Sabine , Shi Chaomei , Sun Fangxian , Tolstykh Tatiana , Weber William , Winter Christopher , Yu Eunsil , Yu Qunyan , Zheng Gang , Wiederschain Dmitri
Published: April 2023

Supplementary Figure Legends. Figure legends for Supplementary Figures 1, 2, 3, and 4.
Supplementary Figure 4 from Anti–miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network Deregulation
Authors: Wagenaar Timothy R. , Zabludoff Sonya , Ahn Sung-Min , Allerson Charles , Arlt Heike , Baffa Raffaele , Cao Hui , Davis Scott , Garcia-Echeverria Carlos , Gaur Rajula , Huang Shih-Min A. , Jiang Lan , Kim Deokhoon , Metz-Weidmann Christiane , Pavlicek Adam , Pollard Jack , Reeves Jason , Rocnik Jennifer L. , Scheidler Sabine , Shi Chaomei , Sun Fangxian , Tolstykh Tatiana , Weber William , Winter Christopher , Yu Eunsil , Yu Qunyan , Zheng Gang , Wiederschain Dmitri
Published: April 2023

Supplementary Figure 4. Pathway analysis of gene expression changes following anti-miR-21 treatment. SKHep1 cells treated with anti-miR-21 were subjected to microarray gene expression analysis. Changes in cellular processes (top) and pathways (bottom) upon anti-miR-21 treatment are shown.